COVID-19 Hydroxycholoroquine Trial Recruitment Approved The MHRA received a request from the University of Oxford, on 17 June, to recommence recruitment to the ‘COPCOV’ trial investigating hydroxychloroquine in the prevention of COVID-19. Green light for COVID-19 trial recruitment The MHRA has approved the recruitment of further participants for a clinical trial by the University of Oxford Published 26 June 2020 From: Medicines and Healthcare products Regulatory Agency The MHRA has approved the recruitment of further participants for a clinical trial investigating hydroxychloroquine in prevention of COVID-19, by the University of Oxford. Dr Siu Ping Lam, Director of Licensing at the
The post COVID-19 Hydroxycholoroquine Trial Recruitment Approved appeared first on Government Online.